ASM Attends UN General AssemblyASM President, Susan Sharp, Ph.D., joined global leaders at the United Nations General Assembly in New York today in a historical meeting to focus on the commitment to fight AMR.
The Department of Health and Human Services (HHS) recently announced the selection of Robin Robinson, Ph.D., as the first director of the Biomedical Advanced Research Development Authority (BARDA), which was established in 2007 in the HHS Office of the Assistant Secretary for Preparedness and Response. In his current role as Deputy Director of BARDA's Influenza and Emerging Disease Program, Dr. Robinson led the successful development, procurement and stockpiling of the world's first H5N1 influenza vaccine approved for human use. BARDA manages Project BioShield, which includes the procurement and advanced development of medical countermeasures for chemical, biological, radiological, nuclear agents, as well as manages the advanced development and procurement of medical countermeasures for pandemic influenza and other emerging infectious diseases that fall outside the auspices of Project BioShield.
The Centers for Disease Control and Prevention (CDC) has released information about the reported high numbers of dengue infections in many countries during 2007. This trend has continued in 2008, notably with the large outbreak currently being reported in Brazil. Proper diagnosis of dengue is important; many other diseases may mimic dengue. Healthcare providers should consider dengue, malaria, and (in South Asia and countries bordering the Indian Ocean) chikungunya in the differential diagnosis of patients who have fever and a history of travel to tropical areas during the 2 weeks before symptom onset.
MMWR Reports of Interest